These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 36668838)

  • 1. Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications.
    Zhou K; Luo W; Liu T; Ni Y; Qin Z
    Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mechanism of blockade of neuroexocytosis by presynaptic neurotoxins.
    Rossetto O; Rigoni M; Montecucco C
    Toxicol Lett; 2004 Apr; 149(1-3):91-101. PubMed ID: 15093253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum neurotoxins: mechanism of action.
    Tighe AP; Schiavo G
    Toxicon; 2013 Jun; 67():87-93. PubMed ID: 23201505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of tetanus and botulinum neurotoxins.
    Montecucco C; Schiavo G
    Q Rev Biophys; 1995 Nov; 28(4):423-72. PubMed ID: 8771234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip.
    Tehran DA; Pirazzini M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29748471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum neurotoxins: mechanism of action and therapeutic applications.
    Montecucco C; Schiavo G; Tugnoli V; de Grandis D
    Mol Med Today; 1996 Oct; 2(10):418-24. PubMed ID: 8897436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and future directions of botulinum neurotoxins for targeting pain processing.
    Pellett S; Yaksh TL; Ramachandran R
    Toxins (Basel); 2015 Nov; 7(11):4519-63. PubMed ID: 26556371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
    Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
    J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analgesic potential of clostridial neurotoxin derivatives.
    Foster KA
    Expert Opin Investig Drugs; 2004 Nov; 13(11):1437-43. PubMed ID: 15500391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins.
    Davletov B; Bajohrs M; Binz T
    Trends Neurosci; 2005 Aug; 28(8):446-52. PubMed ID: 15979165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinal neurotoxins as tools in studies of synaptic mechanisms.
    Thesleff S
    Q J Exp Physiol; 1989 Dec; 74(7):1003-17. PubMed ID: 2576323
    [No Abstract]   [Full Text] [Related]  

  • 12. The Janus faces of botulinum neurotoxin: sensational medicine and deadly biological weapon.
    Osborne SL; Latham CF; Wen PJ; Cavaignac S; Fanning J; Foran PG; Meunier FA
    J Neurosci Res; 2007 May; 85(6):1149-58. PubMed ID: 17387703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action mechanisms of botulinum neurotoxins and tetanus neurotoxins].
    Deloye F; Doussau F; Poulain B
    C R Seances Soc Biol Fil; 1997; 191(3):433-50. PubMed ID: 9295967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum neurotoxin: the ugly duckling.
    Koussoulakos S
    Eur Neurol; 2009; 61(6):331-42. PubMed ID: 19365125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging opportunities for serotypes of botulinum neurotoxins.
    Peng Chen Z; Morris JG; Rodriguez RL; Wagle Shukla A; Tapia-Núñez J; Okun MS
    Toxins (Basel); 2012 Nov; 4(11):1196-222. PubMed ID: 23202312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects.
    Pickett A
    BioDrugs; 2010 Jun; 24(3):173-82. PubMed ID: 20462283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of tetanus and botulinum neurotoxins.
    Montecucco C; Schiavo G
    Mol Microbiol; 1994 Jul; 13(1):1-8. PubMed ID: 7527117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered toxins: new therapeutics.
    Foster KA
    Toxicon; 2009 Oct; 54(5):587-92. PubMed ID: 19264086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor and substrate interactions of clostridial neurotoxins.
    Brunger AT; Rummel A
    Toxicon; 2009 Oct; 54(5):550-60. PubMed ID: 19268493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.
    Lam KH; Yao G; Jin R
    Prog Biophys Mol Biol; 2015 Mar; 117(2-3):225-231. PubMed ID: 25701633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.